Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer
NCT04581109Terminated
- Sponsor
- CHU Montpellier
- Start
- May 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Montpellier. Primary endpoints: EPIDROP technique sensitivity versus CellSearch system sensitivity at 18 months and EPIDROP technique specificity versus CellSearch system specificity at 18 months. Started May 2021; status: terminated.
Beyond the preview
Go deeper on NCT04581109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581109.